GYRBM Antibody

What is GYRBM antibody and what organism does it target?

GYRBM antibody is a polyclonal antibody developed against the GYRBM protein (gene symbol GYRB2) from Arabidopsis thaliana . It specifically targets plant species, making it a valuable tool for researchers investigating DNA gyrase in plant biology . The antibody is developed using recombinant Arabidopsis thaliana GYRBM protein as the immunogen, and it is purified using Protein A/G affinity chromatography to ensure high specificity and low background in experimental applications . The target protein is associated with UniProt Number Q94BZ7 and Entrez Gene ID 830291, which helps researchers verify the specificity of the antibody in their experimental systems .

What are the validated applications for GYRBM antibody in plant research?

The GYRBM antibody has been validated for Enzyme-Linked Immunosorbent Assay (ELISA) and Western Blotting (WB) applications in plant research . For ELISA applications, the antibody can be used to detect and quantify GYRBM protein in plant extracts, providing a sensitive method for protein quantification in various experimental conditions . In Western Blot applications, the antibody can identify the target protein after separation by SDS-PAGE, allowing researchers to determine protein expression levels, post-translational modifications, or protein degradation patterns in different plant tissues or under various experimental treatments .

What is the molecular basis of GYRBM antibody's specificity?

The specificity of GYRBM antibody is derived from its recognition of unique epitopes on the Arabidopsis thaliana GYRBM protein . As a polyclonal antibody raised in rabbits, it contains a diverse population of immunoglobulins that recognize multiple epitopes on the target protein . The antibody-antigen interface involves complex molecular interactions including hydrogen bonds, van der Waals forces, and electrostatic interactions that collectively determine binding specificity and affinity . Recent structural studies on antibody-antigen interactions have revealed that specificity is often determined by complementarity in shape and charge distribution at the binding interface, with 6-20 amino acids on the antibody typically forming the critical contact points with the antigen .

How should I design a Western blot protocol specific for GYRBM protein detection?

For optimal Western blot detection of GYRBM protein, begin with careful sample preparation: homogenize plant tissue in a buffer containing protease inhibitors to prevent degradation . Use the following protocol tailored for plant proteins:

• Separate proteins on 10-12% SDS-PAGE gels (adjust percentage based on GYRBM's molecular weight)

• Transfer to PVDF membrane (recommended over nitrocellulose for plant proteins)

• Block with 5% non-fat milk in TBST for 1 hour at room temperature

• Incubate with GYRBM antibody at 1:1000 dilution overnight at 4°C

• Wash 3× with TBST (10 minutes each)

• Incubate with HRP-conjugated anti-rabbit secondary antibody (1:5000) for 1 hour

• Wash 3× with TBST

• Develop using ECL detection system

Always include appropriate controls: a positive control using the recombinant immunogen protein provided with the antibody, and a negative control using the pre-immune serum to establish specificity . The expected molecular weight should be verified against database information for GYRBM protein to confirm specific detection .

What are the optimal storage and handling conditions for maintaining GYRBM antibody activity?

To maintain optimal activity of GYRBM antibody, store the concentrated antibody at -20°C or -80°C for long-term storage . For routine use, small aliquots should be prepared to avoid repeated freeze-thaw cycles which can significantly reduce antibody activity through protein denaturation and aggregation . When working with the antibody:

• Thaw aliquots quickly at 37°C and immediately transfer to ice

• Dilute in fresh, cold buffer immediately before use

• Add carrier protein (0.1-1% BSA) to diluted antibody solutions to enhance stability

• For short-term storage (1-2 weeks), keep at 4°C with preservative (0.02% sodium azide)

• Avoid exposure to light for conjugated antibodies

• Centrifuge antibody solutions briefly before opening to collect liquid at the bottom of the tube

• Use sterile technique when handling to prevent microbial contamination

These practices will help maintain antibody performance and extend its useful lifetime in research applications .

How can I validate the specificity of GYRBM antibody in my experimental system?

Validating GYRBM antibody specificity requires multiple complementary approaches to ensure reliable results:

The recombinant immunogen protein supplied with the antibody can serve as a positive control in these validation experiments . For definitive verification, consider using techniques like CRISPR-Cas9 to generate gene knockouts, which should eliminate the specific signal if the antibody is truly specific to GYRBM .

How can I optimize ELISA protocols for quantitative detection of GYRBM protein?

For quantitative ELISA detection of GYRBM protein, consider these optimization steps:

• Antigen Capture Optimization: Test different coating conditions (carbonate buffer pH 9.6 vs. PBS pH 7.4) and concentrations (1-10 μg/ml) of capture antibody

• Sample Preparation: For plant samples, use extraction buffers containing 1-2% non-ionic detergents (Triton X-100) to improve protein solubilization

• Antibody Titration: Perform checkerboard titration with different antibody concentrations (1:500 to 1:5000) to determine optimal signal-to-noise ratio

• Detection System: For enhanced sensitivity, consider using avidin-biotin amplification systems

• Standard Curve: Generate a standard curve using purified recombinant GYRBM protein (provided with the antibody kit) at concentrations ranging from 0-1000 ng/ml

Implement these quality control measures:

• Include blank wells (no sample) to measure background

• Include wells with pre-immune serum at the same concentration as the antibody

• Process duplicate or triplicate samples to assess technical variability

• Include spike-recovery tests by adding known amounts of recombinant protein to samples

These approaches ensure accurate quantification of GYRBM protein across different plant samples or experimental conditions .

What are common causes of non-specific binding with GYRBM antibody and how can they be mitigated?

Non-specific binding can significantly compromise experimental results with GYRBM antibody. Common causes and mitigation strategies include:

• Insufficient blocking: Extend blocking time to 2 hours and test different blocking agents (5% BSA, commercial blocking buffers)

• Cross-reactivity with related proteins: Increase washing stringency with higher salt concentration (up to 500 mM NaCl) in wash buffers

• Sample preparation issues: Add protease inhibitors to prevent degradation products that may create unexpected bands

• Secondary antibody cross-reactivity: Test secondary antibody alone to identify non-specific binding

• Antibody concentration: Optimize antibody dilution; too concentrated antibody solutions often increase background

• Sample overloading: Reduce total protein loaded on gels for Western blots

• Buffer compatibility issues: Ensure sample buffers don't interfere with antibody binding

A systematic approach to troubleshooting involves changing one parameter at a time and documenting the effect on specific versus non-specific signals . Comparing the pattern of staining with the pre-immune serum (provided with the antibody) can help distinguish non-specific binding from specific signals .

How can I apply co-immunoprecipitation techniques to study GYRBM protein interactions?

Co-immunoprecipitation (Co-IP) with GYRBM antibody can reveal physiologically relevant protein interactions in plant systems. Follow this optimized protocol:

• Cell/tissue lysis: Homogenize plant tissue in non-denaturing lysis buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate) with protease inhibitors

• Pre-clearing: Incubate lysate with Protein A/G beads alone to remove non-specific binding proteins

• Antibody binding: Add 2-5 μg GYRBM antibody per 500 μg total protein and incubate overnight at 4°C with gentle rotation

• Immunoprecipitation: Add 50 μl Protein A/G beads, incubate 2-4 hours at 4°C

• Washing: Perform stringent washing (4-5 times) with lysis buffer

• Elution: Elute in SDS sample buffer by heating at 95°C for 5 minutes

• Analysis: Analyze by SDS-PAGE followed by Western blotting or mass spectrometry

For validation, perform reciprocal Co-IPs when possible, and include controls with pre-immune serum and IgG-matched controls . Recent studies on antibody-antigen interfaces emphasize the importance of maintaining native protein conformations during Co-IP experiments to preserve physiologically relevant interactions .

How do results with GYRBM antibody compare between ELISA and Western blot techniques?

When comparing ELISA and Western blot results with GYRBM antibody, researchers should consider the fundamental differences between these techniques:

Discrepancies between techniques may indicate:

• Presence of post-translational modifications

• Protein degradation or aggregation

• Cross-reactivity with structurally similar proteins

• Sample preparation artifacts

For comprehensive analysis, both techniques should be employed complementarily, with Western blot confirming the specificity of ELISA results, particularly in novel experimental systems or when unexpected results occur .

What molecular mechanisms underlie the specificity of GYRBM antibody compared to other plant protein antibodies?

The specificity of GYRBM antibody is determined by the unique structural characteristics of the antibody-antigen interface, which distinguishes it from antibodies against other plant proteins . Recent comprehensive analyses of antibody-antigen binding interfaces reveal several molecular mechanisms contributing to this specificity:

The remarkable 66% increase in experimentally determined antibody-antigen structures in 2021 has significantly enhanced our understanding of these molecular mechanisms, allowing for more precise prediction of cross-reactivity and specificity in experimental applications .

How can GYRBM antibody be used in studying plant stress responses and DNA damage repair mechanisms?

GYRBM antibody can be a powerful tool for investigating plant stress responses and DNA damage repair mechanisms through several experimental approaches:

• Expression Analysis: Track GYRBM protein expression levels under various stress conditions (heat, drought, UV, chemical stressors) using Western blot or ELISA to correlate protein abundance with stress response

• Subcellular Localization: Use immunofluorescence microscopy with GYRBM antibody to determine protein redistribution during stress responses, particularly between nuclear and chloroplast compartments

• Post-translational Modifications: Combine GYRBM immunoprecipitation with mass spectrometry to identify stress-induced modifications (phosphorylation, ubiquitination) that may regulate protein function

• Protein-Protein Interactions: Apply co-immunoprecipitation with GYRBM antibody to identify stress-specific interaction partners involved in DNA repair pathways

• Chromatin Immunoprecipitation: If GYRBM functions in DNA binding or chromatin remodeling, ChIP using this antibody can identify genomic regions associated with the protein during stress response

These approaches can reveal how DNA gyrase functions change during plant adaptation to environmental stresses, potentially identifying novel regulatory mechanisms that could be targeted for improving crop resilience . The antibody's specificity for plant proteins makes it particularly valuable for studying plant-specific aspects of DNA metabolism that differ from bacterial or animal systems .

How does the research methodology for GYRBM antibody compare to approaches used with mammalian antibodies?

Research methodologies for GYRBM antibody differ from those used with mammalian antibodies in several key aspects:

• Sample Preparation: Plant tissues contain unique components like cell walls, chloroplasts, and specific secondary metabolites that can interfere with antibody binding, requiring specialized extraction buffers with plant-specific enzyme inhibitors and detergents

• Cross-Reactivity Patterns: Unlike many mammalian antibodies, plant antibodies like GYRBM antibody must be validated across diverse plant species with varying degrees of evolutionary distance, as the conservation patterns differ substantially from mammalian systems

• Fixation Protocols: For immunohistochemistry, plant tissues typically require different fixation protocols than mammalian tissues due to differences in membrane composition and cell wall presence

• Background Reduction: Plant tissue autofluorescence, particularly from chlorophyll and cell wall components, necessitates specific blocking and quenching steps not typically needed in mammalian systems

• Epitope Accessibility: The subcellular localization of plant proteins, often within specialized compartments like chloroplasts or surrounded by cell walls, may require additional permeabilization steps compared to mammalian systems

Similar to approaches used in studying glomerular epithelial cell (GEC) membrane proteins, researchers must consider the specific microenvironment in which the target protein functions when designing experiments with plant antibodies .

What insights from antibody-antigen binding interface analysis can improve GYRBM antibody applications?

Recent advances in antibody-antigen binding interface analysis provide valuable insights for optimizing GYRBM antibody applications:

• Structural Determinants: The remarkable 136% increase in experimentally determined antibody-antigen structures over the past five years has revealed that binding interfaces typically involve 6-20 amino acids on the antibody that form complementary interactions with epitopes on the antigen

• Buffer Optimization: Knowledge of the physicochemical properties of binding interfaces enables rational design of buffer compositions that enhance binding affinity and specificity

• Epitope Mapping: Computational predictions based on structural databases can identify likely epitopes on GYRBM protein, guiding experimental design for epitope mapping studies

• Cross-Reactivity Prediction: Statistical analyses of large structural databases enable more accurate prediction of potential cross-reactivity with related proteins, informing validation experiments

• Binding Kinetics: Understanding the molecular determinants of antibody-antigen binding kinetics helps optimize incubation times and washing conditions in various applications

These insights, derived from the expanding Structural Antibody Database (SabDab) with over 4,638 antibody-antigen structures, provide a solid foundation for experiment optimization and troubleshooting when working with GYRBM antibody .